NCT06345391

Brief Summary

A pain science education (PSE) intervention for children (8-12y) living beyond cancer (CBC) will be developed through a co-creational approach with CBC, their parents and pediatric oncology clinicians. The study will be guided by the Intervention Mapping Protocol.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 15, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 3, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

April 3, 2024

Status Verified

March 1, 2024

Enrollment Period

5 months

First QC Date

March 15, 2024

Last Update Submit

March 26, 2024

Conditions

Keywords

children living beyond cancerpain science educationco-creationchronic pain

Outcome Measures

Primary Outcomes (1)

  • Satisfaction with the co-created intervention

    Information about satisfaction of stakeholders (i.e. children living beyond cancer, their parents, and pediatric oncology clinicians) with various aspects of the co-created PSE intervention (e.g., content, complexity, comfort, delivery, and credibility) will be assessed through a small self-developed questionnaire at the end of the last co-creation and concept mapping session. The items of the questionnaire will be based on the ultimately developed intervention and will also include an open-ended question assessing to what extent the developed PSE intervention is what they needed, with the opportunity to suggest alternative treatment content.

    at the end of the last co-creation/concept mapping session, approximately 6 months

Secondary Outcomes (3)

  • Understandability of the co-created intervention

    at the end of the last co-creation/concept mapping session, approximately 6 months

  • Empowerment with regard to the co-created intervention

    at the end of the last co-creation/concept mapping session, approximately 6 months

  • Ownership of the intervention development

    at the end of each co-creation/concept mapping session, up to 6 months

Study Arms (3)

Children living beyond cancer

Children between 8-12 years with a history of any cancer diagnosis that are currently in the early survivorship phase (\<2y post-treatment).

Other: Co-creation

Parents of children living beyond cancer

Parents of children (8-12 years) living beyond cancer.

Other: Co-creation

Pediatric oncology clinicians

Clinicians (e.g. physician, nurse, physical therapist, occupational therapist, psychologist, child life specialist) currently employed in pediatric oncology.

Other: Concept Mapping

Interventions

Participatory approach maximally and directly involving important stakeholders (bottom-up) to co-create a pain science education intervention for children living beyond cancer.

Children living beyond cancerParents of children living beyond cancer

Concept mapping to create a pain science education intervention for children living beyond cancer.

Pediatric oncology clinicians

Eligibility Criteria

Age8 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children living beyond cancer and their parents will be recruited through patients lists of the participating hospitals (i.e. University Hospital Brussels and University Hospital Ghent), by convenience sampling (e.g. through the research team's networks, calls on social media), and through snowball sampling (i.e. participating dyads search for and encourage other dyads to participate). Oncology clinicians will be recruited from the participating hospitals by email invitation and through the research team's networks. All eligible children, parents, and oncology clinicians will be informed about the study and receive a consent form.

You may qualify if:

  • Children living beyond cancer:
  • history of (any) cancer diagnosis
  • \<2y post-treatment completion (early survivorship phase)
  • fluently Dutch speaking and reading
  • having access to internet/computer (in order to complete online questionnaires)
  • signed informed consent form
  • Parents of children living beyond cancer:
  • fluently Dutch speaking and reading
  • having access to internet/computer (in order to complete online questionnaires)
  • signed informed consent form
  • Pediatric oncology clinicians:
  • currently employed as a physician, nurse, physical therapist, occupational therapist, psychologist, or child life specialist in pediatric oncology
  • fluently Dutch speaking and reading
  • having access to internet/computer (in order to complete online questionnaires)

You may not qualify if:

  • Children living beyond cancer:
  • presence of psychiatric disorders or severe intellectual disability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vrije Universiteit Brussel

Jette, Brussels Capital, 1090, Belgium

Location

MeSH Terms

Conditions

Chronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Sophie Pleysier, MSc

CONTACT

Emma Rheel, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Principal Investigator

Study Record Dates

First Submitted

March 15, 2024

First Posted

April 3, 2024

Study Start

April 1, 2024

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

April 3, 2024

Record last verified: 2024-03

Locations